Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 5-bromo-2,6-di-(1H-pyrazol-1-yl)pyrimidin-4-amine for use in the treatment of cancer

5-bromo-2,6-di-(1H-pyrazol-1-yl)pyrimidin-4-amine for use in the treatment of cancer

US Patent 10561653 · Granted Feb 18, 2020

Estimated economic value: $31,833,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cocrystals of (1R,3S)-3-(5-cyano-4-phenyl-1,3-thiazol-2-ylcarbamoyl)cyclopentane2025
N-benzyl-2-phenoxybenzamide derivatives as prostaglandin E2 (PGE2) receptors mod2024
Crystalline forms of 5-bromo-2,6-di(1H-pyrazol-1- yl)pyrimidin-4-amine and new s2023
Androgen receptor and glucocorticoid receptor modulators2022
Benzamide derivatives as PPAR-gamma modulators2022
Heteroaryl amide derivatives as selective inhibitors of histone deacetylases 1 a2022
1-(4-amino-5-bromo-6-(1H-pyrazol-1-yl)pyrimidin-2-yl)-1H-pyrazol-4-ol and use th2021
1-(4-amino-5-bromo-6-(1H-pyrazol-1-yl)pyrimidin-2-yl)-1H-pyrazol-4-ol and use th2021
1-(4-amino-5-bromo-6-(1H-pyrazol-1-yl)pyrimidin-2-yl)-1H-pyrazol-4-ol and use th2021
1-(4-amino-5-bromo-6-(1H-pyrazol-1-yl)pyrimidin-2-yl)-1H-pyrazol-4-ol and use th2021
1-(4-amino-5-bromo-6-(1H-pyrazol-1-yl)pyrimidin-2-yl)-1H-pyrazol-4-ol and use th2021
Pyridoquinazoline derivatives useful as protein kinase inhibitors2021